- Markets broadly lower amid escalating trade war fears ahead of Trump's "Liberation Day" on Wednesday when new tariffs take effect. US100 fell 0.8%, US2000 dropped 0.65%, and US30 gained 0.56%. S&P 500 briefly entered correction territory, down 10% from February highs.
- Markets in Europe showed a similar trend. The German DAX lost 1.33% today, the French CAC 40 1.58%, and the British FTSE100 0.88%. The Polish WIG20 fell by over 2%.
- Australia’s central bank is set to keep interest rates unchanged on Tuesday as it waits out an election campaign fought on cost-of-living issues and girds for the economic impact of a US-driven upheaval in global trade.
- Gold continues its historic rally, reaching an all-time high of almost $3,150/oz before settling around $3,127. The precious metal is up 18% this quarter – on pace for its best quarterly performance since 1986. Bank of America forecasts $3,500/oz in the next 18 months, while JPMorgan analysts speculate $4,000 could be possible.
- Wall Street lowered forecasts with Goldman Sachs cutting S&P 500 year-end target to 5,700 from 6,200 and raising recession probability to 35% from 20%. Barclays and Yardeni Research also reduced targets, with Yardeni now seeing a 45% chance of recession.
- Tech stocks under pressure with Tesla falling 6% due to tariff concerns and potential impact of CEO Elon Musk's government role on sales. CoreWeave shares dropped 9% in their second day of trading after a disappointing IPO that raised just $1.5 billion versus an initial $4 billion target.
- AMD CEO remains bullish on AI demand despite market skepticism. Lisa Su told Yahoo Finance "the need for computers continues to be immense" as the company closed its $4.9 billion acquisition of ZT Systems to strengthen its hyperscale infrastructure business.
- Pharmaceutical sector hit hard with nearly £8bn ($10.2bn) wiped off market values after FDA vaccine chief Dr. Peter Marks was ousted by Health Secretary Robert F. Kennedy Jr. Moderna plunged 8% (leading S&P 500 decliners), while Pfizer, GSK, AstraZeneca, and other biotech firms also fell sharply.
- Energy market developments include US crude production falling by 305,000 barrels per day in January to 13.15 million bpd, the lowest level since February 2024 and largest monthly decline in a year.
- NYSE launches Texas exchange with Trump Media & Technology Group (DJT) as its first dual listing. NYSE Group President Lynn Martin stated the new offering "will allow companies to capitalize on the pro-business dynamics in Texas."
This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".
